A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer

Conclusion: Concurrent capecitabine and radiation therapy is well-tolerated and demonstrates promising efficacy in urothelial carcinoma, thus offering a tolerable therapeutic option in elderly patients or those with impaired performance status.